Atlas Trials

A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects

Clinical trial NCT01842607 · COMPLETED

Trial details

NCT number
NCT01842607
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2013-05-27
Primary completion
2015-03-13
Enrollment
651

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.